Sprint Bioscience AB's total assets for Q1 2025 were kr33.84M, a decrease of -19.54% from the previous quarter. DE:5JA1 total liabilities were kr30.21M for the fiscal quarter, a -7.86% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.